ROTE WILLIAM E. — SEC insider filings
SEC reporting owner CIK 1698262. 33 insider filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2020-09-22 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 42 legs across 30 filings — 365,493 shares, $17,961,915 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 43.
- Largest priced transaction: sale of 65,104 shares @ $63.12 ($4,109,397) in Travere Therapeutics, Inc., filed 2026-09-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Chief Research Officer | 33 | — | 42 legs · 365,493 sh · $17,961,915 | 43 |
Insider filings — ROTE WILLIAM E.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 39,000 @ $25.25 · Option exercise (M): 39,650 @ $17.96 · Sale (S): 63,907 @ $61.99 · Sale (S): 29,021 @ $62.66 · Sale (S): 3,000 @ $63.65 · Sale (S): 270 @ $65.31 · +10 more | EDGAR |
| 2026-05-06 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 4,250 @ $0 · Sale (S): 2,763 @ $43.95 · Grant/award (A): 8,500 (derivative) @ $0 · Option exercise (M): 4,250 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 9,100 @ $39.09 | EDGAR |
| 2026-04-15 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 14,000 @ $0 | EDGAR |
| 2026-02-03 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 20,090 @ $0 · Sale (S): 12,446 @ $32.87 · Grant/award (A): 53,570 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 60,000 @ $20.61 · Sale (S): 60,000 @ $40.10 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 4,920 · Sale (S): 3,198 @ $21.05 · Option exercise (M): 4,920 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Travere Therapeutics, Inc. (TVTX) | Option exercise (M): 8,000 · Sale (S): 5,200 @ $23.53 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 21,500 @ $0 · Sale (S): 8,951 @ $19.78 · Grant/award (A): 58,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,437 @ $19.46 | EDGAR |
| 2024-09-09 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 6,750 @ $0 · Sale (S): 4,387 @ $11.52 | EDGAR |
| 2024-02-02 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 25,000 @ $0 · Sale (S): 2,174 @ $8.53 · Sale (S): 2,590 @ $8.86 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,062 @ $8.96 | EDGAR |
| 2023-09-05 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 3,300 @ $0 · Sale (S): 1,815 @ $14.71 | EDGAR |
| 2023-05-12 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 825 @ $16.59 | EDGAR |
| 2023-02-02 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 20,250 @ $0 · Sale (S): 2,590 @ $22.25 · Grant/award (A): 54,500 (derivative) @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2023-01-26 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,062 @ $21.50 | EDGAR |
| 2022-05-12 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 750 @ $21.93 · Sale (S): 813 @ $21.52 | EDGAR |
| 2022-02-02 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 9,840 @ $0 · Sale (S): 1,125 @ $27.40 · Grant/award (A): 39,360 (derivative) @ $0 · Grant/award (A): 9,840 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2022-01-26 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 1,875 @ $24.98 | EDGAR |
| 2022-01-12 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 5,000 @ $0 · Sale (S): 2,500 @ $27.40 | EDGAR |
| 2021-08-17 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 4,500 @ $0 · Sale (S): 1,407 @ $17.12 | EDGAR |
| 2021-05-13 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 1,563 @ $19.14 · Sale (S): 1,562 @ $19.46 | EDGAR |
| 2021-02-18 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 1,250 @ $27.35 · Sale (S): 1,250 @ $28.67 | EDGAR |
| 2021-02-09 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,250 @ $31.41 · Sale (S): 2,250 @ $31.58 | EDGAR |
| 2021-02-05 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 4,500 @ $0 | EDGAR |
| 2021-02-03 | 4 | Travere Therapeutics, Inc. (TVTX) | Sale (S): 2,500 @ $28.91 · Sale (S): 1,125 @ $28.91 | EDGAR |
| 2021-02-02 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 5,000 @ $0 · Sale (S): 2,500 @ $30.75 · Sale (S): 1,125 @ $30.75 | EDGAR |
| 2021-01-25 | 4 | Travere Therapeutics, Inc. (TVTX) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 57,500 (derivative) @ $0 | EDGAR |
| 2020-11-17 | 4 | Travere Therapeutics, Inc. (RTRX) | Sale (S): 2,500 @ $23.96 | EDGAR |
| 2020-11-13 | 4 | Retrophin, Inc. (RTRX) | Grant/award (A): 5,000 @ $0 · Sale (S): 2,500 @ $23.62 | EDGAR |
| 2020-09-23 | 4 | Retrophin, Inc. (RTRX) | Sale (S): 1,500 @ $18.48 | EDGAR |
| 2020-09-22 | 4 | Retrophin, Inc. (RTRX) | Grant/award (A): 3,000 @ $0 · Sale (S): 1,500 @ $18.59 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1698262 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs